-+=

Management Team

Adriaan Aarts

Chief Financial Officer

Adriaan (born in 1965) studied Economics at Tilburg University and began his career in banking. After spending two years at Citigroup in Zurich and Paris, he joined ABN AMRO, where…

Read more

Carel Hoyng, MD, PhD

Senior Clinical Scientist, Founder, Key opinion leader Retinal Disease
“My ultimate goal is to find a cure for inherited retinal diseases”
Read more

Rob Collin, PhD

Interim Chief Executive Officer, Founder, Inventor RNA Therapy
“Due to their high specificity, antisense oligonucleotides hold great promise to correct RNA defects underlying many inherited diseases”
Read more

Melita Kaltak, PhD

Chief Scientific Officer
"I'm committed to helping develop solutions for individuals with vision disorders. My goal is to advance antisense oligonucleotides from research to clinical trials, making a difference in the lives of the community affected by Stargardt disease and Usher syndrome."
Read more

Research Team

Erwin van Wijk, PhD

Senior Scientist
"Being able to save vision will be a life-changing event for people with a blinding disorder"
Read more

Femke Bukkems

Research technician
"By researching treatment for retinal disorders, I hope to help and eventually cure patients with these diseases so that they can once again enjoy all that is happening around them."
Read more

Drug Development Team

Bianca Matthee

Drug Development Advisor

Bianca Matthee, PharmD, MSc in Pharmaceutical Sciences from Utrecht University, brings over 17 years of expertise in Life Sciences. As the founder of BMPharm, she advises and fills interim management…

Read more

Cathaline den Besten, PhD

Drug Development Advisor

Cathaline den Besten is a seasoned nonclinical expert with over 30 years of experience in translational drug development, toxicology and DMPK. She has gained wide-ranging R&D experience from early research…

Read more

Clinical Operations Team

Tom Koemans, PhD

Clinical Research Associate
"I like to contribute to the development of these innovative RNA therapies and to treat and cure degenerative diseases of the retina. By this, I hope to improve health care worldwide. "
Read more

General Advisory Board

Markwin Velders

General Advisor

Dr. Markwin Velders obtained his PhD in molecular immunology at the Leiden University and worked as scientist and assistant professor at Loyola University Chicago, authoring over 40 peer reviewed papers.…

Read more

Maarten Scholten

General Advisor

After obtaining his law degree at the University of Amsterdam (The Netherlands), Mr. Scholten started his career as an attorney at the Amsterdam and New York offices of Loeff &…

Read more

Lucy Peltenburg, PhD

General Advisor

After obtaining her PhD in molecular biology of cancer at the University of Leiden, Dr. Lucy Peltenburg worked as a post-doc at the Biology department at the University of California…

Read more

Clinical Advisory Board

Camiel J.F. Boon, MD, PhD

Clinical advisor

Camiel Boon, MD, PhD, FEBO, is a Consultant Ophthalmologist at Amsterdam University Medical Centers and at Leiden University Medical Center (the Netherlands). Already at the age of 36, he was…

Read more

Mario Fsadni, MD

Clinical advisor

Owner, International Pharm-Med Ltd. and Pharmaceuticals Consultant

Read more
Back To Top